A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore, has identified eight new "signatures" of DNA patterns (gains and/or losses) in breast cancer. By analysing nearly 2,800 genomes, the team systematically profiled changes in the number of DNA copies in breast cancer, with the goal of better understanding the underlying mechanisms of tumour development and evaluating how these structural genomic changes relate to clinical outcomes.

The identified signatures could help refine future diagnostic tools, as well as to better match breast cancer patients with targeted therapies.

An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM).

A blood test that detects tumour DNA circulating in the bloodstream may help select the most effective treatment options for cancer patients whose tumours have started to spread, according to one of the largest randomised controlled trials of its kind presented at the Congress of the European Society for Radiotherapy and Oncology.